Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer.

Conclusion: These findings suggest the serum exosomal miR-620 as a promising diagnostic and prognostic noninvasive biomarker in NSCLC patients. PMID: 33343663 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33343663?dopt=Abstract

Source: Journal of Oncology - December 23, 2020 Category: Cancer & Oncology Tags: J Oncol Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Study